跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,023 条关于
“THRIVE-1”
全部
61,023
临床试验
36,863
药物
7,270
机构
1,396
资讯
15,494
去年
Protara Therapeutics Reports 72% Complete Response Rate in NMIBC Trial, Secures $100M Funding
去年
Protara Therapeutics Receives FDA Fast Track Designation for IV Choline Chloride
去年
Protara Therapeutics Announces Progress in TARA-002 and IV Choline Chloride Programs
去年
Protara Therapeutics Announces Key Milestones for 2025, Including NMIBC and LM Data
2年前
Viridian Therapeutics' Veligrotug Shows Promise in Phase III Thyroid Eye Disease Trial
去年
Viridian's Veligrotug Shows Promise in Phase 3 Trial for Chronic Thyroid Eye Disease
去年
First-of-its-kind Gene Editing Treatment Saves Baby with Rare Genetic Disorder
2个月前
ARPA-H Launches $160 Million THRIVE Program to Advance Custom Gene Editing for Rare Diseases
上个月
Elevar Therapeutics to Present Three Abstracts at ESMO 2026, Including Phase 2 THRIVE Trial of Rivoceranib in Thymic Tumors
2个月前
ARPA-H THRIVE Awards $73.4 Million to Advance Personalized Gene-Editing Platforms for Rare Pediatric Diseases
第 1 页,共 1550 页
上一页
下一页